Vitalhub Corp. (VHI) Earnings Call Transcripts
Vitalhub Corp.'s Latest Earnings Call - Q1 FY2026
In the first quarter of 2026, Vitalhub Corp. reported a significant revenue increase of 47% year-over-year, totaling $31.9 million, driven by strong growth in recurring revenue. The company achieved an adjusted EBITDA margin of 25%, reflecting operational efficiency improvements. Management maintained a positive outlook, signaling continued growth in annual recurring revenue (ARR) and a commitment to strategic M&A activities, although they acknowledged some macroeconomic headwinds affecting sales cycles.
Reported metrics
| Metric | Value |
|---|---|
| Total Revenue | $31.9 million (beat) |
| Recurring Revenue | $23.9 million (inline) |
| Adjusted EBITDA | $8 million (beat) |
| Adjusted EBITDA Margin | 25% (positive) |
| Annual Recurring Revenue (ARR) | $99.1 million (positive) |
| Gross Margin | 82% (positive) |
Guidance from management
Management maintained a positive outlook for 2026, targeting lower double-digit ARR growth. Matlow stated, 'We're trying to get to the rule of 40, right? And we're at the 10%, 11% range right now.'
What management said
Yes. I think that's -- we're trying to get to the rule of 40, right? And we're at the 10%, 11% range right now, and that's what we're aiming for. You never know what could happen here. It could be higher, it could be lower just because of how we do our revenue. It comes from all different spots. But yes, so far, that's where it looks like for the next quarter for sure.
Yes. I'm always around. I know it's a really busy season. There's some analysts that probably were on some other calls, but I'm sure they'll reach out to me with some questions. Christian is always around. I'm always around. We're excited to keep progressing here and go as steady as she goes. So just another few inches forward for Vital Hub, and we just keep moving forward gradually. We're in this for the long game. ...
What analysts pressed on
Analysts expressed concerns regarding the sales cycle's length and potential macroeconomic impacts on deal sizes. There were also questions about the integration of new products and the regulatory environment for AI solutions.
Main topics on the call
- Strong Revenue Growth — Vitalhub reported total revenue of $31.9 million, representing a 47% increase year-over-year, with recurring revenue contributing $23.9 million or 75% of total revenue. Management stated, 'We are happy to be executing on...
- Improved EBITDA Margin — The adjusted EBITDA margin increased to 25% from 23.6% in the prior quarter, indicating improved operational efficiency. CEO Dan Matlow noted, 'We're back to 25% adjusted EBITDA.'
- ARR Growth and Future Prospects — The company closed the quarter with $99.1 million of ARR, reflecting 11% organic growth year-over-year. Matlow expressed optimism about future growth, stating, 'We still see some significant things coming on the Novari s...
- M&A Activity and Strategy — Management highlighted ongoing M&A opportunities, particularly in Europe, with a focus on companies that have successfully implemented products in the U.K. Matlow mentioned, 'We expect to close transactions in '26 for su...
Read the full Vitalhub Corp. transcript (Q1 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.
About Vitalhub Corp.
Vitalhub Corp. (VHI) is a publicly listed company in the Health Care Technology industry, within the Health Care sector. It trades on TSX and is based in CA. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 18 calls on record spanning November 11, 2022 to August 7, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 18 Vitalhub Corp. earnings call transcripts on record, spanning November 11, 2022 to August 7, 2026. Based on this history, Vitalhub Corp. reports quarterly. The most recent call on file is dated August 7, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- VHI
- Exchange
- TSX
- Country
- CA
- Sector
- Health Care
- Industry
- Health Care Technology
- Calls on record
- 18
- First call
- November 11, 2022
- Most recent
- August 7, 2026
- Reporting cadence
- quarterly
| Quarter | Date | |
|---|---|---|
| Q2 FY2026 | Aug 7, 2026 | Read transcript → |
| Shareholder/Analyst Calls | Jun 26, 2026 | Read transcript → |
| Q1 FY2026 | May 8, 2026 | Read transcript → |
| Q4 FY2025 | Mar 19, 2026 | Read transcript → |
| Shareholder/Analyst Calls | Jun 27, 2025 | Read transcript → |
| Q1 FY2025 | May 9, 2025 | Read transcript → |
| Q4 FY2024 | Mar 28, 2025 | Read transcript → |
| Q3 FY2024 | Nov 14, 2024 | Read transcript → |
| Q2 FY2024 | Aug 9, 2024 | Read transcript → |
| Shareholder/Analyst Calls | Jun 27, 2024 | Read transcript → |
| Q1 FY2024 | May 10, 2024 | Read transcript → |
| Q4 FY2023 | Mar 22, 2024 | Read transcript → |
| Q3 FY2023 | Nov 10, 2023 | Read transcript → |
| Q2 FY2023 | Aug 11, 2023 | Read transcript → |
| Shareholder/Analyst Calls | Jun 28, 2023 | Read transcript → |
| Q1 FY2023 | May 12, 2023 | Read transcript → |
| Q4 FY2022 | Mar 24, 2023 | Read transcript → |
| Q3 FY2022 | Nov 11, 2022 | Read transcript → |